« Back
Home /
Trastuzumab

Trastuzumab

Manufacturer	MedChem Express
Category	Oncology Antibodies Primary Antibodies By Organ Colorectal Cancer Breast Cancer
Type	Antibody Monoclonal
Specific against	other
Amount	25 mg
Item no.	HY-P9907-25mg
Targets	EGFR
CASRN	180288-69-1
eClass 6.1	32160702
eClass 9.0	42030590
Available
Product Description	Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
StorageTemperature	Store at 4°C for 2 years, do not freeze
Shipping	Blue Ice
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	N/A
Clinical_Information	Launched
Manufacturers Research_Area	Cancer
Solubility	H2O
Isoform	ErbB2/HER2
Pathway	Antibody-drug Conjugate/ADC Related; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-P9907-25mg-safety-datasheet.pdf